1. Home
  2. GDTC vs ALTS Comparison

GDTC vs ALTS Comparison

Compare GDTC & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • ALTS
  • Stock Information
  • Founded
  • GDTC 2018
  • ALTS 1976
  • Country
  • GDTC Singapore
  • ALTS United States
  • Employees
  • GDTC N/A
  • ALTS N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • GDTC Health Care
  • ALTS
  • Exchange
  • GDTC Nasdaq
  • ALTS NYSE
  • Market Cap
  • GDTC 33.4M
  • ALTS 35.9M
  • IPO Year
  • GDTC 2023
  • ALTS N/A
  • Fundamental
  • Price
  • GDTC $2.37
  • ALTS $3.52
  • Analyst Decision
  • GDTC Buy
  • ALTS
  • Analyst Count
  • GDTC 1
  • ALTS 0
  • Target Price
  • GDTC $5.00
  • ALTS N/A
  • AVG Volume (30 Days)
  • GDTC 24.9K
  • ALTS 196.8K
  • Earning Date
  • GDTC 01-01-0001
  • ALTS 12-27-2024
  • Dividend Yield
  • GDTC N/A
  • ALTS N/A
  • EPS Growth
  • GDTC N/A
  • ALTS N/A
  • EPS
  • GDTC N/A
  • ALTS N/A
  • Revenue
  • GDTC $330,254.00
  • ALTS $7,110,000.00
  • Revenue This Year
  • GDTC $14.71
  • ALTS N/A
  • Revenue Next Year
  • GDTC N/A
  • ALTS N/A
  • P/E Ratio
  • GDTC N/A
  • ALTS N/A
  • Revenue Growth
  • GDTC N/A
  • ALTS N/A
  • 52 Week Low
  • GDTC $1.20
  • ALTS $0.50
  • 52 Week High
  • GDTC $5.50
  • ALTS $5.26
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 45.29
  • ALTS 65.16
  • Support Level
  • GDTC $2.43
  • ALTS $2.53
  • Resistance Level
  • GDTC $3.00
  • ALTS $4.00
  • Average True Range (ATR)
  • GDTC 0.41
  • ALTS 0.35
  • MACD
  • GDTC -0.03
  • ALTS 0.09
  • Stochastic Oscillator
  • GDTC 21.60
  • ALTS 73.03

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

Share on Social Networks: